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Global increase in replication fork speed during a
p57KIP2-regulated erythroid cell fate switch
Yung Hwang,1 Melinda Futran,1* Daniel Hidalgo,1* Ramona Pop,1† Divya Ramalingam Iyer,2
Ralph Scully,3 Nicholas Rhind,2 Merav Socolovsky1‡
Cell cycle regulators are increasingly implicated in cell fate decisions, such as the acquisition or loss of pluripo-
tency and self-renewal potential. The cell cycle mechanisms that regulate these cell fate decisions are largely
unknown. We studied an S phase–dependent cell fate switch, in which murine early erythroid progenitors
transition in vivo from a self-renewal state into a phase of active erythroid gene transcription and concurrent
maturational cell divisions. We found that progenitors are dependent on p57KIP2-mediated slowing of replica-
tion forks for self-renewal, a novel function for cyclin-dependent kinase inhibitors. The switch to differentiation
entails rapid down-regulation of p57KIP2 with a consequent global increase in replication fork speed and an
abruptly shorter S phase. Our work suggests that cell cycles with specialized global DNA replication dynamics
are integral to the maintenance of specific cell states and to cell fate decisions.
INTRODUCTION
The timing and execution of developmental cell fate decisions are
incompletely understood. The cell cycle is implicated in such decisions
through interactions between cell cycle and transcriptional regulators
(1–3) and through cell cycle phase–specific receptiveness to differenti-
ation cues (4–7). Reconfiguration of lineage-specific chromatin loci,
a prerequisite for the execution of cell fate decisions, was hypothesized
to require S phase, because the passage of the replication fork transiently
disrupts nucleosomes (8, 9). However, developmental transitions and
associated dynamic changes in chromatin are possible in the absence
of S phase (10–15). Notwithstanding these findings, S phase is essential
for activation or silencing of some genes in yeast (16, 17) and for a subset
of cell fate decisions in metazoa (18–22), although the precise role
and underlying mechanisms linking S phase to these decisions remain
unclear.
We recently identified an S phase–dependent cell fate decision that
controls the transition from self-renewal to differentiation in themurine
erythroid lineage (23). Erythroid progenitors at the colony-forming unit
erythroid (CFUe) stage (24) undergo a number of self-renewal cell
divisions before switching into a phase of active erythroid gene tran-
scription, known as erythroid terminal differentiation (ETD), during
which they mature into red cells while undergoing three to five addi-
tional cell divisions. The switch from self-renewal to ETD is tightly regu-
lated because it determines the number of CFUe progenitors and
erythroid output (24, 25). Many of the transcription factors that drive
the ETD, including GATA-1, Tal-1, and Klf1, are well characterized
(26, 27). However, the cellular context and signals that determine their
timing of activation are not well understood.
To address these questions, we studied the murine fetal liver, an
erythropoietic tissue rich in erythroid progenitors. Our recent work using
this model system showed that the transition from the self-renewing
CFUe to ETD in vivo coincides with the up-regulation of the cell surface
marker CD71, making it accessible to molecular study (23). We found
that ETD is activated during early S phase, in a rapid cell fate switch
that comprises a number of simultaneous commitment events, includ-
ing the onset of dependence on the hormone erythropoietin (Epo) for
survival, chromatin reconfiguration (23), and an unusual process of global
DNA demethylation (28). These commitment events are dependent on
S-phase progression, because their induction can be reversibly pre-
vented by reversibly arresting DNA replication (23).
Here, we explore the requirement for S-phase progression during
this cell fate switch, by askingwhether S phase at the time of the switch
might differ from S phase in preceding cycles. We previously noted
that the switch to ETD coincides with an increase in intra–S-phase
DNA synthesis rate, possibly indicating a shorter S phase (23, 28). Al-
though the length of the G1 phase is well documented as a regulatory
target of growth factors and differentiation signals (4, 7), much less is
known regarding the regulation of S-phase length inmammals. By con-
trast, thewell-studied postfertilization cleavage cycles ofmodel organisms,
such as frog and Drosophila, last only minutes and comprise an ex-
tremely short S phase; S phase lengthens abruptly at the midblastula
transition (29–32). Thismarked change in S-phase length is the result of
altered firing efficiency of origins of replication, which transition from
synchronous and efficient firing during the short cleavage cycles to
asynchronous and less efficient firing at the midblastula transition
(30, 33). Although far less is known regarding the possible regulation
of S-phase length during mammalian development, older reports have
noted transient S-phase shortening during key cell fate decisions, in-
cluding shortening of S phase to <3 hours in epiblasts of mouse and
rat embryos as they transition through the primitive streak and become
either endoderm or mesoderm (34–36). The relevance of altered S-phase
duration tomammalian differentiation and the underlyingmechanisms
are not known.
In this work, we determine that the transition from CFUe to ETD
entails a transient shortening of S phase, in part regulated by p57KIP2, a
member of theCip/Kip family of cyclin-dependent kinase (CDK) inhib-
itors (CDKIs) (37–40). In a novel function for this protein, we find that
p57KIP2 prolongs the duration of S phase in self-renewing progenitors,
a function essential for their viability both in vivo and in vitro. Themech-
anism controlling S-phase duration does not involve altered firing of
replication origins but, instead, altered speed of replication forks. In the
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presence of p57KIP2, replication forks are slower; p57KIP2 down-regulation
with activation of the ETD results in globally faster forks.
RESULTS
Activation of ETD coincides with S-phase shortening
To study the activation of ETD in vivo, we divided erythroid lineage
cells in the fetal liver into six sequential developmental subsets, subsets
0 to 5 (S0 to S5), based on the expression of cell surface markers CD71
andTer119 (Fig. 1A and fig. S1A) (23, 41, 42). Subsets S0 and S1 contain
progenitorswithCFUe colony-forming potential (giving rise to colonies
of 16 to 32 red cells within 72 hours), whereas subsets S2 to S5 contain
maturing erythroblasts undergoing ETD, marked by the expression of
the erythroid cell surface marker Ter119 (23). We have previously
shown that the switch to ETD in CFUe progenitors involves a series
of events that are synchronized with the cell cycle and that can be
followed in an orderly manner by observing changes in CD71 and
Ter119 expression (23). Thus, CFUe progenitors undergo a limited
number of self-renewal divisions while in the S0 subset, including the
last cell division of the CFUe progenitor stage. The progenies of this last
cell division (Fig. 1A, colored purple) undergo a sharp increase in cell
surface CD71 when in early S phase of the cycle, transitioning into the
S1 subset. This transition, which depends on S-phase progression,
marks the switch to ETDand the onset of Epo dependence. The ensuing
induction of erythroid genes, including expression of the cell surface
marker Ter119 and transition into the S2 subset, takes place around
the time that these cells undergo the nextmitosis. Therefore, the S1 sub-
set contains largely S-phase cells during a rapid transition fromCFUe to
ETD (Fig. 1A) (23).
To analyze the cell cycle characteristics of CFUe progenitors during
this transition, we injected pregnant female mice with the nucleoside
analog bromodeoxyuridine (BrdU) and harvested embryos 30min after
injection. The cartoon in fig. S1B illustrates two distinct parameters
of replication that may be obtained from this experiment. First, the
number of cells in S phase is measured on the basis of their incorpora-
tion of BrdU into replicating DNA (BrdU+ cells). Second, the rate of
BrdU incorporation into S-phase cells, measured as the BrdU median
fluorescence intensity within the S-phase gate (fig. S1B, dashed black
line), indicates the intra–S-phase rate of DNA synthesis (43, 44). We
found that, in spite of being exposed to the same BrdU pulse in vivo,
S-phase cells within a single fetal liver vary substantially in their BrdU
incorporation rate, depending on their stage of differentiation. Spe-
cifically, in the shown example in fig. S1C, BrdU median fluorescence
intensity (MFI) is 54% higher in S1 compared with S0 of the same fetal
liver (fig. S1, C and D). This result is consistent with our earlier data in
subsets sorted from pooled fetal livers, which showed that the average
BrdU incorporation rate in S1 cells is 55 ± 13% higher than in S0 [mean
± SEM of six independent experiments, P = 0.02 (23, 28)]. This result
indicates a substantially faster DNA synthesis rate in S-phase cells in the
S1 subset, compared with S0 cells, and suggests that genome replication in
S1 cellsmight be completed sooner, resulting in a shorter S phase (fig. S1B).
Here, we examined this possibility by using a double-nucleoside
label approach (45, 46). We injected pregnant female mice sequentially
with two distinct deoxynucleoside analogs of thymidine: first with a
pulse of 5-ethynyl-2-deoxyuridine (EdU), followed, after an interval
“I,” by a BrdU pulse (Fig. 1, B to E). We explanted fetal livers immedi-
ately (20 min) following the second BrdU pulse, isolated S0 and S1 cells
by fluorescence-activated cell sorting (FACS), and analyzed cells for
incorporation of EdU, BrdU, or both. To calculate S phase and the
cell cycle length, we measured two parameters. First, we measured
the EdU+BrdU− cell fraction, which represents cells that were in S phase
during the first EdU pulse but have exited S phase during the ensuing
interval I. This cell fraction is therefore proportional to the duration of
I (Fig. 1B). Second, we measured the fraction of cells that are BrdU+
(including both BrdU+EdU+ andBrdU+EdU− cells), which corresponds
to the fraction of cells in S phase just before embryo harvest. (Note that,
because of the finite but unknown clearance time for the first EdU pulse
in vivo, cells entering S phase during the interval I continue to incorpo-
rate EdU, denoted by a hashed green line in Fig. 1B. It is therefore not
possible to use the fraction of EdU+ cells as a measure of the fraction
of cells in S phase.) Five independent experiments, with I either 1 or
2 hours, and including one experiment in which the EdU and BrdU
labelswere reversed, resulted in the expected linear relationship between
I and the fraction of cells that exited S phase (r2 = 0.95 and 0.85 for S1
and S0, respectively; Fig. 1D). We calculated the length of the cell cycle
as 15 ± 0.3 hours (mean ± SE) and 5.8 ± 0.1 hours for S0 and S1 cells,
respectively, suggesting a marked cell cycle shortening at the S0/S1
transition. S-phase shortening contributed to the shortening of the
cycle, decreasing by >40% [from 7.1 ± 0.3 hours in S0 to 4.1 ± 0.2 hours
in S1 cells (mean ± SEM)], which corresponds to a 73 ± 15% increase in
intra–S-phase DNA synthesis rate. This shortening agrees with the
increased BrdU incorporation rate at the transition from S0 to S1
(fig. S1, C and D) (23), validating the latter approach as a measure of
intra–S-phase DNA synthesis rate in our system. In addition to S-phase
shortening, G1 and G2-M phases also become substantially shorter with
the switch from S0 to S1 (Fig. 1E).
Our results are consistent with early reports documenting a doubling
time of 6 hours for murine CFUe in vivo (24) and an extremely short S
phase of 2.5 hours for rat erythroblasts (45). Here, we go beyond these
findings, clearly linking cell cycle and S-phase shortening with a cell fate
switch, from self-renewal in S0 to ETD in S1.
p57KIP2 is expressed in S phase, slowing intra–S-phase DNA
synthesis rate
To investigate themechanismof S-phase shortening in S1 cells, we com-
pared the expression of cell cycle regulators in S0 and S1.We previously
found that p57KIP2 is expressed in S0 and is rapidly down-regulatedwith
the transition to S1 (23). By contrast, other members of the Cip/Kip
family, p21CIP1 and p27KIP1, are not significantly expressed in S0 and
S1 and are instead induced later, at the very end of ETD (23). p57KIP2
was previously documented to act in the G1 phase, where it inhibits the
transition from G1 to S phase (37, 38). Here, we examined the cell cycle
phase in which p57KIP2 is expressed, by sorting freshly explanted S0 and
S1 cells enriched for either G1 or S phase, based on their DNA content
(Fig. 2A). We found that the highest levels of p57KIP2 mRNA and pro-
tein were attained in S phase of S0 cells (Fig. 2, B and C). There was a
significant, 50-fold decline in p57KIP2 mRNA in S-phase cells between
S0 and S1 (P = 0.0079, Mann-Whitney test), whereas there was no
significant difference in p57KIP2 mRNA levels between S0 and S1 cells
in G1 phase of the cycle, where it was expressed at lower levels.
These findings suggested a possible S-phase function for p57KIP2. To
test this, we used short hairpin RNA (shRNA) to target p57KIP2 in S0
cells that were explanted and cultured in the presence of Epo and
dexamethasone (Dex), conditions that promote CFUe self-renewal
(47). In addition to the expected increase in the number of S-phase cells,
knockdown of p57KIP2 resulted in the doubling of intra–S-phase DNA
synthesis rate (which increased by 2 ± 0.29–fold, mean ± SD, P = 0.005)
relative to cells transduced with nonsilencing shRNA (Fig. 2, D and E).
SC I ENCE ADVANCES | R E S EARCH ART I C L E
Hwang et al., Sci. Adv. 2017;3 : e1700298 26 May 2017 2 of 15
Fig. 1. S-phase shortening at the transition from self-renewal to differentiation in vivo. (A) Schematic depicting sequential flow cytometric fetal liver subsets S0 to
S5 during erythroid differentiation (see flow cytometric profile in fig. S1A). Seventy percent of S0 and all of S1 cells have CFUe potential. The transition from S0 to S1
marks a switch from CFUe self-renewal to differentiation. The S0/S1 switch is S phase–dependent and takes place in the early S phase of the last CFUe generation (23).
(B) Double-deoxynucleoside label approach. Pregnant female mice were injected with EdU at t = 0 and with BrdU following a time interval I. Fetal livers were harvested
and analyzed shortly after the BrdU pulse. Cells in S phase of the cycle at the time of the EdU pulse incorporate EdU into their DNA and retain this label as they progress
through the cycle (represented as green cells). Cells entering S phase continue to take up EdU during the interval I, until EdU is cleared from the blood (shown as
dashed green circles). Similarly, cells that are in S phase during the BrdU pulse become labeled with BrdU (red). The “green only” cells (EdU+BrdU−) represent cells that
were in S phase during the first EdU pulse but have exited S phase during the interval I. This cell fraction f is proportional to the length of the interval I, as long as I is
shorter than the gap phase (G2 + M + G1). By trial and error, we found that, for I to be shorter than the gap phase of S1 cells, it needs to be ≤2 hours. The linear
relationship between I and f can be expressed in terms of the cell cycle length I/Tc = f, where f is the cells that exited S phase in interval I [measured as % (EdU
+BrdU−)
cells], I is the interval between EdU and BrdU pulses, and Tc is the cell cycle length. This relationship gives the length of the cycle as Tc = I/f. The length of S phase, Ts, can
then be calculated from fraction s, of all cycling cells that take up the BrdU label (%BrdU+), as Ts = s × Tc. In preliminary experiments, we used longer BrdU pulses. These
showed that nearly all cells were labeled with BrdU, suggesting that essentially all cells are cycling. Therefore, we made no corrections for the fraction of cycling cells.
(C) Representative experiment as described in (B). Pregnant female mice were pulsed with EdU, followed by a BrdU pulse after an interval of 2 hours. Upper two panels
show fetal liver cells from mice that were pulsed only with EdU, or only with BrdU, but processed for labeling for both deoxynucleosides in the same way as the double-
labeled mice. Lower panels show EdU and BrdU labeling in fetal liver subsets that were explanted after the second pulse, sorted by flow cytometry, and then each
processed for EdU and BrdU incorporation. In this specific experiment, a third of all S1 and S2 cells exited S phase in a 2-hour interval, giving a cell cycle length of 2/0.33 =
6 hours; only 14% of S0 exited S phase in the same time interval, giving a cell cycle length of 2/0.14 = 14.3 hours. Because 64% of S1 and 44% of S0 cells are BrdU+, their
S-phase lengths are 0.64 × 6 = 3.84 hours and 0.44 × 14.3 = 6.3 hours, respectively. (D) Summary of five independent experiments as described above. The linear relation-
ship between I and the cells that exited S phase, f, allows calculation of a mean cycle and length. S1, empty symbols; S0, filled symbols. r2 = 0.95 for S1 and 0.85 for S0.
Results in table are mean ± SE. Pulses were reversed (BrdU first, EdU second) in one experiment, without effect on results (included here). The y axis intercepts are not at
0 because it takes approximately 20 min for peak absorption of each deoxynucleoside (fetal livers are explanted 20 min after the second injection). (E) Durations of cell cycle
and cell cycle phases. The length of each cell cycle phase was calculated by multiplying the fraction of cells in each cell cycle phase following the second pulse by the total cell
cycle length [measured as in (D)].
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We also examined the effect on S phase of p57KIP2 overexpression in
S0 cells. We previously found that this led to cell cycle and differentiation
arrest at the S0/S1 transition (23). Here, we subdivided transduced S0 cells
digitally into gates based on their expression level of p57KIP2, as indicated
by an hCD4 reporter linked through an IRES to p57KIP2 (Fig. 2F) (23).
We found that p57KIP2 exerted dose-dependent slowing of intra–S-phase
DNA synthesis rate (Fig. 2F and fig. S2). As expected, in addition, p57KIP2
inhibited the transition from G1 to S in a dose-dependent manner (Fig.
2F). A degradation-resistant mutant of p57KIP2, p57 T329A, was more po-
tent in its ability to slow down intra–S-phase DNA synthesis rate, whereas
its ability to inhibit the G1- to S-phase transition was comparable to wild-
type p57KIP2 (Fig. 2F). Together, both our knockdown andoverexpression
experiments suggest that p57KIP2 is a candidate inhibitor of intra–S-phase
DNA synthesis rate, capable of prolonging S-phase duration in S0 cells.
Fig. 2. p57KIP2 regulates intra–S-phase DNA synthesis rate. (A) DNA content histograms of freshly explanted and sorted fetal liver cells enriched for either G1 or S
phase, from either the S0 or S1 subsets. DNA content histograms of the sorted subsets are overlaid on the DNA content histograms of the parental S0 or S1 populations.
DNA content was visualized with the DNA dye Hoechst 33342. Representative of five independent sorts. (B) p57KIP2 mRNA expression is highest in S phase of S0 cells.
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed in samples sorted as in (A). Data are means ± SEM for five independent sorting
experiments. Statistical significance was assessed with the Mann-Whitney test. (C) Western blotting on fetal liver samples sorted as in (A). Representative of two
experiments, each with 30 fetal livers. (D) Intra–S-phase DNA synthesis rate following retroviral transduction of S0 cells with shRNA targeting p57KIP2 or with a non-
silencing control shRNA (NS). Cells were pulsed with BrdU for 30 min, 20 hours after transduction. (E) Summary of four independent p57KIP2 knockdown experiments as
in (D). Intra–S-phase DNA synthesis is expressed relative to controls transduced with nonsilencing shRNA. Samples were pulsed with BrdU for 30 min, 20 to 60 hours
after transduction. Statistical significance was assessed with a paired t test. (F) p57KIP2 exerts dose-dependent inhibition of DNA synthesis within S-phase cells. S0 cells were
transduced with p57KIP2–internal ribosomal entry site (IRES)–hCD4 (ICD4) or with “empty” vector (MICD4). Eighteen hours after transduction, cells were pulsed with BrdU for
30 min. Transduced cells were divided into gates 1, 2, and 3 (top left panel), expressing increasing levels of hCD4. Corresponding cell cycle analyses for each gate are shown
(top right panels), including BrdU MFI for the S-phase gates in italics. See also fig. S2. Lower panels: Similar analysis relating MICD4, p57-ICD4, or p57T329A-ICD4 expression (hCD4-
MFI) with either the number of cells in S phase (lower left panel) or BrdU MFI (lower right panel). Representative of six independent experiments.
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p57KIP2-deficient embryos are anemic as a result of
abnormal erythropoiesis
To test whether p57KIP2 regulates S-phase duration in erythroid pro-
genitors, we examined embryos deleted for the cdkn1c gene, which en-
codes p57KIP2 (48, 49). p57KIP2 deficiencywas previously found to result
in perinatal death, associated with a variety of developmental abnorm-
alities, including abnormal abdominal muscles, intestines, kidney, adre-
nals, and bones (48, 49). However, erythropoiesis in p57KIP2-deficient
mice was not examined. p57KIP2 is a paternally imprinted gene. We
examined p57KIP2−/− and p57KIP2+/−m (heterozygous embryos that
inherited the maternal null allele) at midgestation. We found that,
whereas a proportion of the p57KIP2-deficient embryos were morpho-
logically abnormal, the majority had preserved gross normal morphol-
ogy, enabling us to easily identify and explant the fetal liver (Fig. 3A).
p57KIP2-deficient embryos appeared paler than wild-type littermates
(Fig. 3A) and were anemic (hematocrit: 19.5 ± 1.1 for wild-type embryos
versus 14.0 ± 1.0 and 13.0 ± 1.6 for p57KIP2−/− and p57KIP2+/−m embryos, re-
spectively, mean ± SE) (Fig. 3B). Anemia in the p57KIP2-deficient
embryos was likely the result of abnormal erythropoiesis because these
embryos had smaller fetal livers containing significantly fewer cells
Fig. 3. Anemia and abnormal erythropoiesis in p57KIP2-deficient embryos. (A) p57KIP2+/−m and wild-type littermate embryos on embryonic day 13.5 (E13.5). The
p57KIP2+/−m embryo is pale and has a smaller fetal liver. (B) p57KIP2-deficient embryos are anemic, as seen from their significantly reduced hematocrit (n = 64 embryos,
E13.5). (C) Fewer fetal liver cells in p57KIP2-deficient embryos compared with wild-type littermates (n = 121 embryos). (D) Abnormal erythroid differentiation in p57KIP2-
deficient embryos. A representative CD71/Ter119 plot showing fewer S3 erythroblasts in the p57KIP2−/− embryo compared with wild-type littermate. (E) Increased
frequency of S0 cells in p57KIP2-deficient fetal livers, measured as in (D), from 7.9 ± 0.46% (mean ± SE, wild-type embryos, n = 36) to 10.6 ± 1% (p57KIP2−/−, n = 14)
and 10.0 ± 0.38% (p57KIP2−/−m, n = 25). The absolute number of S0 cells is unchanged because the total number of fetal liver cells is reduced proportionally to 67%
of wild-type for both p57KIP2−/−m and p57KIP2−/− embryos [see (C)]. (F) Reduced ratio of S3 to S0 erythroblast number, measured as in (D), for a total of 74 embryos.
(G) Inverse correlation between apoptosis in the S0 or S1 subsets and S3 frequency in the fetal livers of p57KIP2-deficient embryos. No significant correlation was seen in
the fetal livers of wild-type littermates. Fetal livers were freshly explanted and immediately stained for annexin V binding. n = 75 embryos.
S C I ENCE ADVANCES | R E S EARCH ART I C L E
Hwang et al., Sci. Adv. 2017;3 : e1700298 26 May 2017 5 of 15
(Fig. 3C). Flow cytometric profiles of the fetal liver suggested abnormal
erythroid differentiation (Fig. 3, D and F). Thus, the ratio of S3 to S0
cells in p57KIP2-deficient fetal livers was significantly reduced (Fig. 3,
D and F). Notably, the absolute number of S0 cells per fetal liver was
unchanged compared with wild-type littermate embryos because the
frequency of S0 cells within the fetal liver of p57KIP2-deficient embryos
was increased in proportion to the decrease in the total number of fetal
liver cells (Fig. 3, C andE). The reduced S3 to S0 ratio therefore indicates
a failure of S0 cells to differentiate efficiently into S3 erythroblasts. This
failure is explained by increased cell death: There was a significant
negative correlation between the frequency of S3 cells in the p57KIP2-
deficient fetal livers and apoptosis of either S0 (r = −0.77, P < 0.0001;
Fig. 3G) or S1 cells (r = −0.86, P < 0.0001; Fig. 3G). In contrast, there
was no significant correlation between the number of apoptotic S0 or
S1 cells and S3 frequency in wild-type littermate embryos (Fig. 3G).
Together, these results show that p57KIP2 deficiency causes anemia,
secondary to cell death at the S0 and S1 progenitor stage, resulting in
reduced number of maturing S3 erythroblasts.
Premature S-phase shortening and DNA damage are
found in p57KIP2-deficient S0 progenitors
We examined the cell cycle status in p57KIP2-deficient fetal livers, by
subjecting pregnant femalemice at midgestation to a 30-min pulse of
BrdU. Fetal livers were then explanted and individually analyzed for
intra–S-phase DNA synthesis rate (Fig. 4, A and B). In wild-type
embryos, intra–S-phase DNA synthesis rate in S0 cells was 65 ± 0.02%
of the peak intra–S-phase DNA synthesis rate in S1 cells of the same
fetal liver (mean ± SE, n = 29) (Fig. 4, A and B), in agreement with
our observation of S-phase shortening at the S0/S1 transition (fig. S1, C
andD, and Fig. 1, B to E). By contrast, intra–S-phase DNA synthesis rate
of littermate p57KIP2-deficient S0 cells was significantly faster, reaching
80 ± 0.05% (p57KIP2−/−, n = 12) and 80 ± 0.07% (p57KIP2+/−m, n =
18) of the peak intra–S-phase DNA synthesis rate of the corresponding
S1 cells in each fetal liver (P < 0.004; Fig. 4, A and B).
The prematurely fast intra–S-phase DNA synthesis rate in p57KIP2-
deficient S0 cells may have contributed to their increased apoptosis
(Fig. 3G). We found a significant increase in the number of gH2AX-
positive S0 cells in freshly explanted p57KIP2-deficient fetal livers
(Fig. 4, C and D). DNA content analysis of gH2AX-positive S0 cells
in p57KIP2-deficient fetal livers shows that they are distributed in S phase
of the cycle, although fewer gH2AX-positive cells reach late S phase (Fig.
4, C, E, and F). Thus, the DNA contents of S- and G2-M–phase cells in
the S0 subset of each fetal liver were 153 ± 1.2% and 198 ± 2.2% of the
DNA content in G1, respectively (mean ± SEM for 17 p57
KIP2+/−m
embryos); the DNA content of gH2AX-positive cells in the same fetal
livers was 121 ± 3.6% of the G1 content (Fig. 4, E and F). These findings
suggest that gH2AX-associatedDNAdamage occurred in S phase of the
cycle, and raise the possibility that it was a consequence of the prema-
turely fast intra–S-phase DNA synthesis rate in these cells. We found
that S-phase cells that were also positive for gH2AX incorporated little
or no BrdU, consistent with S-phase slowing or arrest secondary to
DNA damage and replicative stress (Fig. 4, E and F).
The elevated number of gH2AX-positive cells in p57KIP2-deficient
embryos persisted for the remainder of erythroblast differentiation
(fig. S3,A andB).Notably, wild-type S1 cells showed relatively low levels
of gH2AX staining, suggesting that they are adapted in some way to
high rates of DNA synthesis (fig. S3B).
In summary, our analysis of p57KIP2-deficient embryos in vivo un-
covers a novel intra–S-phase function for p57KIP2 as a suppressor of
global DNA synthesis rate. p57KIP2 exerts this function in early ery-
throid CFUe progenitors in the S0 subset, increasing S-phase duration
and enhancing cell viability, at least in part by reducing replicative stress.
The premature shortening of S phase in p57KIP2-deficient S0 cells sug-
gests that loss of p57KIP2 is sufficient to induce S-phase shortening.
p57KIP2 down-regulation is therefore a likely mechanism underlying
S-phase shortening during the S0/S1 cell fate switch.
p57KIP2 is essential for self-renewal of CFUe in vitro
We next examined whether we could model the S-phase function of
p57KIP2 in vitro. Glucocorticoids slow or arrest the differentiation of
CFUe progenitors in culture, promoting extensive self-renewal instead
(47, 50).Withdrawal of glucocorticoids from the culture precipitates the
prompt inductionofETDand its completionwithin~72hours (47,51, 52).
The precise mechanism by which glucocorticoids promote self-renewal
is not fullyunderstood, but several pathwayshavebeen implicated recently
(53–55). Here, we found that CFUe undergoing self-renewal in vitro in
the presence of the synthetic glucocorticoid Dex expressed p57KIP2
mRNA and protein (Fig. 5, A and B). Withdrawal of Dex resulted in
rapid induction of erythroid gene transcription and also in a rapid
(<24 hours) loss of p57KIP2 expression (Fig. 5, A and B). These changes
in p57KIP2 expression were associated with corresponding cell cycle
changes: CFUe undergoing self-renewal in the presence of Dex had a
slow intra–S-phase DNA synthesis rate that increased abruptly with the
withdrawal of Dex (Fig. 5C) (in measurements taken 20 to 60 hours
after Dex withdrawal, BrdU MFI increased by 74 ± 29%, mean ±
SEM, P = 0.04). The stimulatory impact of p57KIP2 down-regulation
on intra–S-phaseDNAsynthesis rate followingDexwithdrawalmirrors
our observations in vivo, during the switch to ETD at the S0/S1 transition
(fig. S1, C and D, and Fig. 1, C to E).
Next, we assessed the role of p57KIP2 during CFUe self-renewal in
vitro. We established Dex cultures from individual fetal livers of either
p57KIP2-deficient orwild-type littermate embryos. By day 6, the number
of self-renewing cells in the wild-type cultures increased 50-fold. By
contrast, there was no amplification of cells in cultures from p57KIP2−/−
fetal livers, suggesting a novel, essential role for p57KIP2 during Dex-
dependent self-renewal in vitro (Fig. 5D and fig. S4A; n = 5 independent
cultures from individual p57KIP2−/− embryos and 4 cultures from wild-
type littermates). p57KIP2+/−m cultures showed an intermediate but signif-
icantly reduced amplification compared with wild type (17-fold) (n = 4
independent p57KIP2+/−m cultures and 4 cultures from wild-type litter-
mates) (Fig. 5D and fig. S4A). The difference between p57KIP2−/− and
p57KIP2+/−m cultures is likely explained by a low level of expression of
p57KIP2 in the p57KIP2+/−m cultures (Fig. 5E), which became evident with
increasing days in culture (fig. S4, B and C). It may represent a selective
advantage for cells inwhich the imprinted p57KIP2 allelewas incompletely
silenced, further underscoring the importance of p57KIP2 expression to
CFUe self-renewal. Notably, there was no compensatory up-regulation
of either p21CIP1 or p27KIP2 in Dex cultures of p57KIP2-deficient cells
(fig. S4, B and C).
The failure of p57KIP2-deficient CFUe to undergo self-renewal was
associated with a substantial increase in cell death (fig. S5). The intra–
S-phase DNA synthesis rate in cultures of p57KIP2-deficient CFUe was
increased compared with matching wild-type cultures (Fig. 5F). Further,
consistent with our observations in vivo, the frequency of gH2AX-
positive cells was also elevated (Fig. 5G). DNA damage associated with
faster replication is therefore a likely cause of cell death in p57KIP2-
deficient CFUe in vitro, analogous to the death of S0 CFUe in vivo
(Figs. 3G and 4D). DNA damage leading to cell death may potentially
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explain the apparently paradoxical requirement for a CDK inhibitor
during self-renewal and population growth. We were able to restore
self-renewal potential to the p57KIP2−/− CFUe cultures by transducing
the p57KIP2−/− cells with retroviral vectors expressing p57KIP2 (Fig. 5H),
indicating that this effect is cell-autonomous.
In summary, we successfully modeled in vitro the novel functions
that we first uncovered for p57KIP2 during S phase of CFUe progenitors
in vivo. Our results show that p57KIP2 is expressed in self-renewing
CFUe both in vitro and in vivo, where it slows intra–S-phase DNA syn-
thesis rate, protects cells from DNA damage during DNA replication,
and promotes cell viability. The switch to differentiation both in vivo and
in vitro entails rapid down-regulation of p57KIP2, with ensuing increased
intra–S-phase DNA synthesis rate and S-phase shortening.
p57KIP2-mediated CDK inhibition underlies its
S-phase functions
TheCip/Kip familymember p21CIP1 interactswith proliferating cell nu-
clear antigen (PCNA), inhibiting S-phase DNA synthesis during the
Fig. 4. Prematurely short S-phase and replication-associated DNA damage in p57KIP2-deficient fetal liver. (A) Premature increase in intra–S-phase DNA synthesis
rate, measured as BrdU MFI, in p57KIP2-deficient embryos. Representative cell cycle analysis of p57KIP2+/−m and wild-type littermate embryos. Embryos were pulsed in
vivo with BrdU for 30 min before fetal livers were explanted. (B) Premature increase in intra–S-phase DNA synthesis rate in p57KIP2-deficient embryos. Data summary,
analyzed as in (A); n = 29 (+/+), 12 (−/−), and 18 (+/−m). For each embryo, S-phase BrdU MFI in S0 is expressed as a percentage of S-phase BrdU MFI in S1 of the same
fetal liver. (C) Increased gH2AX in S0 cells of p57KIP2-deficient embryos. Representative examples of freshly explanted fetal livers of p57KIP2-deficient embryos and wild-
type littermates, labeled with an antibody against gH2AX. DNA content was measured using 7-amino-actinomycin D (7AAD). See also fig. S3. (D) Increased gH2AX in S0
cells of p57KIP2-deficient embryos. Summary of data obtained as in (C) for a total of n = 79 embryos. gH2AX measured in arbitrary fluorescence units. (E) Distribution of
gH2AX labeling, DNA content, and BrdU incorporation in G1, S, or G2-M phases of the cell cycle and in gH2AX-positive cells, all in the S0 subset of a single p57
KIP2−/− fetal
liver. Embryos were pulsed in vivo with BrdU for 30 min, and fetal livers were harvested, fixed, and labeled for BrdU incorporation, DNA, and gH2AX. S0 cells were
subdivided digitally into cell cycle phase gates based on their DNA content and BrdU incorporation. Cells positive for gH2AX were gated based only on gH2AX signal
regardless of cell cycle phase. (F) p57KIP2-deficient gH2AX-positive S0 cells are slowed or arrested in S phase. Data summary for 17 p57KIP2−/+m fetal livers, analyzed as in
(E). Each data point is BrdU MFI (bottom) or median DNA content (top) for all cells in a specific category (G1, S, G2-M, or gH2AX-positive) in a single fetal liver. BrdU MFI
and median DNA content were normalized to their respective values in G1 cells of the S0 subset in each fetal liver.
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Fig. 5. p57KIP2 is essential toCFUe self-renewal in vitro. (A) p57KIP2 mRNA levels during CFUe self-renewal in vitro and following the switch to differentiation. Wild-type
S0 cellswere cultured for 5 days in self-renewalmedium (“Dex+ Epo”). Cells werewashed and thenplaced either in differentiationmedium (“Epo”) or back in self-renewalmedium
(“Epo + Dex”). Dex withdrawal leads to rapid down-regulation of p57KIP2 and to concurrent rapid induction of erythroid genes, such as a-globin or b-globin. mRNA measured by
qRT-PCR, normalized to b-actin, and expressed relative to t = 0. (B) Western blot and protein band quantification during CFUe self-renewal in vitro and following the switch to
differentiation. Experiment as in (A); on day 0, CFUe progenitorswere replaced either in self-renewalmedium (Epo+Dex) or in differentiationmedium (Epo). The p57KIP2 bandwas
identified using control cells transducedwith retroviral vector expressing p57KIP2, as in (E). The uppermost band on the p57KIP2 blot is an unrelated cross-reacting band seen in
Epo +Dex cultures [see (E)]. Legend as in (A), except that blue diamonds and red circles represent a-globin. (C) Cell cycle status of CFUe during self-renewal in vitro (Epo +Dex)
and 20 to 60 hours following Dex withdrawal (Epo). BrdU MFI in Epo is expressed relative to its value in matched control cells undergoing Dex-dependent self-renewal. Top:
Representative example. Bottom: Summary of sevenmatched cultures from three independent experiments. Statistical significance, paired t test. (D) p57KIP2-deficient S0 CFUe
cells fail to self-renew in vitro. S0 cells derived from individual wild-type or littermate p57KIP2-deficient fetal livers were cultured inmedium containing Epo +Dex. Cell numbers
are relative to t = 0,mean ± SE of four (for +/−m) or five (for−/−) embryos. See also fig. S4A. (E) Western blot of p57KIP2 protein on day 9 of Dex-dependent CFUe self-renewal in
vitro. Control 3T3 cells transduced with either empty vector or vectors expressing each of two p57KIP2 isoforms are also shown. Fetal liver cells express only the shorter 335–
amino acid isoform of p57KIP2. Low levels of the p57KIP2 protein are also detectable in p57KIP2+/−m cells following 9 days of culture in Epo + Dex (see also fig. S4, B and C). Note
that the top band is an unrelated cross-reacting band. (F) Increased intra–S-phase DNA synthesis rate in p57KIP2-deficient CFUe undergoing Dex-dependent self-renewal in
vitro for 6 days. BrdUMFI in the S-phase gate is expressed relative to thewild-type littermate value. Representative of three independent experiments. (G) Increased number of
gH2AX-positive cells in p57KIP2−/− CFUe undergoing Dex-dependent self-renewal, relative to wild-type littermate culture. Representative of three independent experiments.
(H) p57KIP2 rescues p57KIP2-deficient CFUe self-renewal. p57KIP2-deficient S0 cells were transduced with low-titer virus (viral supernatant at the indicated dilutions) encoding
p57KIP2 or with empty vector. Cells transduced with p57KIP2 showed significant improvement in self-renewal. Wild-type S0 cells transduced in parallel showed a reduction in
self-renewal rate. (I) The CDK inhibitor drug roscovitine rescues self-renewal of p57KIP2-deficient CFUe. p57KIP2−/− S0 cells and wild-type S0 cells from littermate embryos were
harvested and cultured in self-renewal medium containing Epo + Dex in the presence or absence of roscovitine. See also fig. S6B.
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DNA damage response (56, 57). However, murine p57KIP2 lacks a
PCNA interaction domain (58). To investigate the mechanisms
underlying p57KIP2-mediated regulation of S-phase duration, we gener-
ated two distinct p57KIP2 point mutants within its conserved CDK-
binding motif, p57W50G and p57F52A/F54A (59, 60). Neither of these
mutants, when expressed in S0 cells, significantly inhibited intra–S-
phase DNA synthesis rate, whereas cells transduced in parallel with
similar levels of wild-type p57KIP2 successfully slowed or arrested S phase
(fig. S6A). This result suggests that CDK binding by p57KIP2, and the
likely ensuing CDK inhibition, mediates its intra–S-phase slowing of
DNA synthesis.
We also investigated whether CDK inhibition could underlie the es-
sential role that p57KIP2 plays inmaintaining the viability of self-renewing
CFUe. We treated p57KIP2-deficient fetal liver CFUe with the CDK
inhibitor roscovitine, which preferentially inhibits S-phase cyclin/CDK
activity (61).We found that a low concentration of roscovitine (0.5 mM)
successfully rescued Dex-dependent self-renewal and expansion of
p57KIP2-deficientCFUewhile having little effect on the normal expansion
of CFUe cultures derived fromwild-type littermates (Fig. 5I). Population
growth in cultures containing roscovitine was the result of CFUe self-
renewal, as shown by their preserved CFUe colony potential (fig. S6B).
Thus, paradoxically, inhibition of CDK activity promotes CFUe viabil-
ity and self-renewal potential, in agreement with the essential require-
ment for p57KIP2 for these functions. Together, these results show that
CDK inhibition is the likely mechanism through which p57KIP2 both
suppresses intra–S-phaseDNAsynthesis rate andpromotes the viability
and self-renewal potential of early erythroid progenitors.
Faster replication forks underlie S-phase shortening at the
S0/S1 transition
CDK activity is required for the firing of origins of replication (62, 63).
Suppression of CDK activity, leading to reduced origin firing, was re-
cently implicated in the lengthening of S phase at the midblastula
transition (64). Given the role of p57KIP2 both in CDK inhibition
and in slowing intra–S-phase DNA synthesis, we sought to determine
whether therewere associated changes in origin firing frequency. To this
end, we usedDNA combing, a single-molecule DNA fiber approach that
allows effects on origin firing and fork progression to be deconvoluted
(65, 66). We explanted littermate wild-type and p57KIP2+/−m fetal livers
at midgestation, allowing fetal liver cells to recover for 4 hours at 37°C.
We then pulsed the cells for 10min with 25 mMof the deoxynucleoside
analog iododeoxyuridine (IdU). This was followed by a pulse of an
eightfold higher concentration of a second deoxynucleoside analog,
chlorodeoxyuridine (CldU), to abruptly switch from IdU to CldU
and allow determination of fork directionality (Fig. 6A). The fetal liver
cells were then placed on ice, and S0 and S1 cells were sorted by flow
cytometry. Genomic DNAwas combed from each of the wild-type and
p57KIP2+/−m S0 and S1 populations, by isolating and stretching on glass
coverslips. Combed DNAwas stained for IdU (green fluorescence) and
CldU (red fluorescence) incorporation and for single-stranded DNA
(Fig. 6B, blue fluorescence). We measured distances between adjacent
origins and the speed of forks during the IdU pulse (Fig. 6B). Only forks
that moved throughout the IdU pulse, as reflected by immediately ad-
jacent and consecutive blue, green, and red/yellow tracks, were included
in the analysis of fork speed (Fig. 6B). (Of note, the beginning of CldU
incorporation into the replication bubble is recognized at the point of
first appearance of red fluorescence, whether or not green IdU fluores-
cence is simultaneously also present, together labeling as yellow; this is
because intracellular IdU is still present at the onset of the second pulse.
Where all three antibodies label DNA, the resulting color is white.)
About 20 Mb was examined for each of the wild-type and p57KIP2+/−m
S0 and S1DNA, with an average fiber length of 1Mb for each of the four
samples (fig. S7A). We found no significant difference in the inter-
origin distance between wild-type S0 and S1 cells or between wild-type
and corresponding p57KIP2+/−m cells (Fig. 6C and fig. S7B). Fork speed
in wild-type S1 cells was increased by 56% compared to wild-type S0
(2.43 ± 0.11 versus 1.56 ± 0.08 kb/min in S1 and S0, respectively, mean
± SE, P < 10−8). A similar result was obtained in an independent exper-
iment in which S0 and S1 cells from a different inbred wild-type mouse
strain (BALB/c) were similarly analyzed (fig. S8, A and B). Therefore,
S-phase shortening in S1 in wild-type cells is the result of a significant
global increase in fork processivity and does not reflect a change in
origin firing efficiency.
Consistent with our earlier result showing premature S-phase shorten-
ing in p57KIP2-deficient embryos (Fig. 4, A and B), we found a 35%
increase in fork speed of p57KIP2+/−m S0 cells compared with wild-type
S0 cells (2.11 ± 0.09 kb/min versus 1.56 ± 0.08 kb/min, respectively; P =
10−5) (Fig. 6, C to E). Finally, there was a further 30% increase in fork
speed with the transition from S0 to S1 in p57KIP2+/−m fetal liver (P =
0.0004; Fig. 6, C to E). Thus, p57KIP2 normally restrains S0 DNA syn-
thesis rate by inhibiting fork processivity, as indicated by the elevated
fork speed in p57KIP2+/−m S0 cells. Although fork speed in p57KIP2+/−m
S0 cells is substantially faster than in wild-type S0, it is nevertheless still
somewhat slower than fork speeds seen in S1 of the same fetal livers
(Fig. 6, C and E). Together, these findings suggest that S-phase shorten-
ing at the S0 to S1 transition in wild-type cells is the result of down-
regulation of p57KIP2, which restrains intra–S-phaseDNAsynthesis rate
in S0 cells by globally suppressing the processivity of replication forks.
We also used DNA combing to analyze the underlying mechanism
of p57KIP2-mediated slowing of DNA synthesis rate during Dex-
dependent CFUe self-renewal in vitro. In agreement with our findings
in vivo, p57KIP2 deficiency resulted in significantly faster replication
forks, with no significant change in inter-origin distance (fig. S8C).
DISCUSSION
We describe an acute change in S-phase duration and in the underlying
dynamics ofDNAreplication, integral to an S phase–dependent erythroid
cell fate decision.We show that the transition from self-renewal to ETD
inCFUe progenitors entails a rapid increase in intra–S-phaseDNA syn-
thesis rate, resulting in a 40% shorter S phase. S-phase shortening is the
result of an abrupt, global increase in the processivity of replication
forks.We identify the CDKI p57KIP2 as a principal regulator of this pro-
cess. p57KIP2 is expressed in S phase of self-renewing CFUe progenitors,
where, through novel functions for this protein, it restrains the speed of
replication forks, protecting cells from replication-associated DNA
damage and maintaining cell viability. p57KIP2 down-regulation during
the switch to ETD causes the observed increase in replication fork speed
and a shorter S phase. Finally, we show that CDK inhibition by p57KIP2
is a likely mediator of its S-phase functions.
Three independent lines of evidence support our finding that S phase
becomes faster and shorter during this cell fate switch. First, intra–S-
phase DNA synthesis rate, as measured by BrdU incorporation rate,
increased by ~50% (fig. S1) (23, 28). Second, the double-deoxynucleoside
label approach, which measures the fraction of cells that leave S phase
during a known time interval, independently confirmed S-phase
shortening, from 7 to 4 hours (Fig. 1). Third, we found a global, ~50%
increase in the speed of replication forks, as measured by DNA combing
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(Fig. 6 and fig. S8A). In addition to these findings in vivo, activation of
ETD in Dex-dependent CFUe cultures in vitro is also tightly associated
with S-phase shortening (Fig. 5F)—a process that is similarly caused by a
global increase in replication fork speed (fig. S8C).
It is well established that DNA replication is reprogrammed during
differentiation, as reflected by changes in usage of replication origins
and in the timing of replication of chromatin domains (67–69). Our
work shows that, in addition, the switch from self-renewal to differen-
tiation fundamentally alters the replication program in an additional
key respect through a global increase in replication fork speed. Inmodel
organisms, marked developmental changes in S-phase duration have
been clearly linked to changes in origin firing (30). The speedof replication
forks was implicated as a regulatory target in the DNA damage response
(70–73) but not in developmental decisions in normal physiology. A
recent report of faster forks in germinal center B cells receiving T cell help
(74), together with our findings here in erythroid progenitors, raise the
possibility that regulatory changes in global fork speedmaybe an intrinsic
part of mammalian physiological developmental programs.
It is unclear at this time how faster DNA synthesis rate might affect
chromatinmetabolism.We previously found that the rapid increase in
intra–S-phase DNA synthesis rate at the S0/S1 transition is required for
an unusual process of replication-dependent global DNA demethylation,
Fig. 6. Global increase in replication fork speed at the transition from S0 to S1, regulated by p57KIP2. (A) Experimental design. Fetal livers were individually
explanted and allowed to recover for 4 hours at 37°C. After genotyping, all embryos of the same genotype (either +/+ or +/−m) were pooled and pulsed with IdU for
10 min, followed by CldU. Cells were then placed at 4°C, sorted into S0 and S1 subsets by flow cytometry, and processed for DNA combing. (B) Portion of a DNA fiber
illustrating the identification and measurement of replication structures. For clarity, the same fiber is shown twice, with (bottom) or without (top) the blue fluorescence
channel. IdU tracks are labeled green and are used to measure fork speed. CldU tracks are labeled red or yellow because, in addition to CldU (red), they contain DNA
incorporating residual IdU (green). The red/yellow tracks are used to obtain fork directionality. Note that for fiber sections, where there is equivalent staining for red,
blue, and green (which may occur during the second pulse), the fiber appears white (the sum total of red, green, and blue in the RGB color format); this does not reflect
saturation of signal. See also fig. S9 for an example of a full microscope field. The blue fluorescence allows assessment of the DNA fiber continuity between replication
bubbles or forks. This therefore allows localization of origins (marked “o”) as either equidistant from two forks proceeding in opposite directions or in the center of a
green (IdU) track bordered by two red (CldU) tracks. The former is an origin that fired before the IdU pulse, whereas the latter is an origin that fired during the IdU pulse.
Identification of origins allows the measurement of inter-origin distances as shown. Fork speed was measured as the length of green (IdU) tracks (in kilobase) for forks
that moved throughout the IdU pulse (immediately adjacent blue, green, and red tracks) and divided by the duration of the pulse (10 min). (C) Scatter plots showing
inter-origin distances (top) and fork speeds (bottom) for a single experiment, in which littermates p57KIP2+/−m and wild-type embryos were analyzed. See fig. S7 for
additional analysis including fiber length distributions. P values are for a two-tailed t test of unequal variance between the indicated samples. Inter-origin distance was
not significantly different between any of the samples. (D) Examples of fork trajectories during the 10-min IdU pulse from the data set in (C). The yellow dashed line
indicates the transition from IdU to CldU. Only the IdU track was used for measurement of fork speed. (E) Violin plots for the data shown in (C).
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which functions to accelerate erythroid gene transcription (28). Thus, an
intriguing possibility is that the elevated speed of the replication fork
reduces the efficiency of DNAmethylation and potentially alters oth-
erDNAmethylation–dependent epigeneticmarks, thereby affecting cell
fate. Increased fork speed per se, although necessary, is not sufficient for
precipitating a cell fate decision because p57KIP2-deficient S0 cells did
not appear to undergo premature ETD in spite of their prematurely fast
DNA synthesis rate.
Our work identifies a novel S-phase function for the CDKI p57KIP2.
p57KIP2 is an established negative regulator of the transition from G1 to
S phase, although it was shown to associate with and inhibit both G1-
and S-phase cyclin/CDK complexes in vitro (37, 38). Here, we pres-
ent several lines of evidence strongly suggesting that p57KIP2 lengthens
S phase by globally suppressing replication fork processivity. We found
that p57KIP2 mRNA and protein were specifically expressed in S phase
of S0 CFUe (Fig. 2, A to C). Knockdown (Fig. 2, D and E) or exogenous
overexpression of p57KIP2 in these cells (Fig. 2F and fig. S2) correspond-
ingly altered intra–S-phase DNA synthesis in a dose-dependent manner.
Finally, in p57KIP2-deleted embryos, intra–S-phase DNA synthesis rate
and global fork speed were both increased by ~50% in S0 cells in vivo
(Figs. 4, A and B, and 6, C to E) and in vitro (Fig. 5F and fig. S8C).
Unlike p21CIP1, which interacts with PCNA to retard replication
forks during the DNA damage response (57, 75), the slowing of S phase
by p57KIP2 depends on its binding and likely inhibition of cyclin/CDK
complexes (fig. S6). Our work therefore suggests that, in addition to
the known requirement for CDK activity in origin firing (62, 63), it also
regulates the processivity of replication forks. Future work will be needed
to test this hypothesis and to identify the critical CDK targets.
We found that p57KIP2 promotes the viability of self-renewing CFUe
progenitors in S0 in vivo (Fig. 3G) and in vitro (Fig. 5D and fig. S5).
Viability and self-renewal were restored to p57KIP2-deficient CFUe in
vitro by retroviral transduction of p57KIP2 (Fig. 5H) or by treatment
with the CDK inhibitor drug roscovitine (Fig. 5I), demonstrating the
cell-autonomous and cell-specific, CDK-inhibitory role of p57KIP2
in these functions. The apparently paradoxical requirement for
CDK inhibition in the expansion of CFUemight be explained, at least
in part, by the replication stress that results in its absence. Replication
stress, which entails the slowing or stalling of replication fork progres-
sion and/or DNA synthesis (70), is evident in p57KIP2-deficient cells
from the increased number of gH2AX-positive cells that are largely
arrested in S phase of the cycle (Figs. 4, C to F, and 5G and fig. S3).
Therefore, by restraining the speed of replication forks, p57KIP2 protects
CFUe cells from replication stress and promotes their viability. Unlike
S0 cells, S1 cells do not undergo increased apoptosis, in spite of their
faster replication forks. Further, S1 cells have lower levels of gH2AX
than S0 cells. It will therefore be of interest to investigate whether the
transition from S0 to S1 entails an adaptation that preserves the viability
of these cells in the face of faster forks. Nevertheless, we previously
found that cells at the S0/S1 transition are particularly sensitive to hy-
droxyurea (23), a finding thatmight be explained by the increased speed
of replication forks.
These novel S-phase functions of p57KIP2 may also underlie the ap-
optosis and abnormal development of non-erythroid tissue progenitors
in p57KIP2 embryos (48, 49) and in patients with Beckwith-Wiedemann
syndrome secondary to p57KIP2 mutations (76, 77). Specifically, hema-
topoietic stem cells (HSCs) deficient in p57KIP2 have a severe deficit in
self-renewal capacity, which impairs their ability to engraft and was
attributed to reduced quiescence (78, 79). Our work suggests that, in
addition, p57KIP2 may enhance HSC self-renewal by restraining in-
tra–S-phase DNA synthesis rate and reducing replication-associated
DNA damage. The finding that p57KIP2 is an essential mediator of
Dex-dependent CFUe expansion cultures provides a novel insight
into the mechanism by which glucocorticoids sustain these cultures,
and is of potential translational relevance in the development ofmass
production of erythroid progenitors in vitro that rely on this culture
system (52, 80).
In conclusion, our work uncovers previously unknown regulation of
S-phase replication dynamics that is integral to cell developmental states
in the erythroid lineage. It shows that CDK inhibition and slow forks are
essential to the viability of self-renewing progenitors and that a rapid
global increase in fork speed takes place with the switch to differentia-
tion. It identifies the Cip/Kip CDKI protein p57KIP2 as a regulator of
fork speed and raises the possibility of similar mechanisms operating
during other instances of S phase–dependent cell fate decisions.
MATERIALS AND METHODS
Mice
Female mice heterozygous for a deletion of the cdkn1c gene (B6.129S7-
Cdkn1ctm1Sje/J, Jackson Laboratory stock no. 000664) were bred with
wild-type C57BL/6J mice or male cdkn1c heterozygous mice. All
experiments were done with littermate p57KIP2-deficient or wild-type
control embryos. All embryoswere genotyped before further processing
of the fetal livers.
Isolation and flow cytometric analysis of
erythroid progenitors
Fetal livers were harvested frommidgestationmouse embryos (E12.5 to
E13.5), mechanically dissociated, labeled with antibodies to CD71 and
Ter119 and with lineage markers, and sorted by flow cytometry as
described (23, 81). Cells were sorted on a FACSAria (BD Biosciences)
using a 100-mmnozzle. Flow cytometric analysis was done on an LSR
II (BD Biosciences) cytometer. FACS data were analyzed using the
FlowJo software (Tree Star Inc.). In some experiments, S0 cells were
isolated from fetal liver cells using EasySep magnetic beads (StemCell
Technologies) by negative sorting for CD71, Ter119, Gr1, Mac1,
and CD41.
Antibodies used in flow cytometric and
EasySep purifications
The following antibodieswere used in flow cytometric andEasySeppur-
ifications: phycoerythrin (PE)/Cy7 rat anti-mouseCD71 (RI7217) (Bio-
Legend 113812), PE rat anti-mouse Ter119 (Ter119) (BD Biosciences
553673), allophycocyanin (APC) rat anti-mouse Ter119 (Ter119) (BD
Biosciences 557909), APC rat anti-mouse Ter119 (Ter119) (BD Bio-
sciences 557909), biotin rat anti-mouse CD71 (C2) (BD Biosciences
557416), biotin rat anti-mouse Ter119 (BD Biosciences 553672), biotin
rat anti-mouse Ly-6G and Ly-6C/Gr1 (RB6-8C5) (BD Biosciences
553125), biotin rat anti-mouse CD11b/Mac1 (M1/70) (BD Biosciences
557395), biotin rat anti-mouse CD41 (MWReg30) (Thermo Scientific
MA1-82655), fluorescein isothiocyanate (FITC) rat anti-mouse Ly-6G
and Ly-6C/Gr1 (RB6-8C5) (BD Biosciences 553127), FITC rat anti-
mouse CD11b/Mac1 (M1/70) (BD Biosciences 557396), FITC rat anti-
mouseCD41 (MWReg30) (BDBiosciences 553848), FITC rat anti-mouse
CD45R/B220 (RA3-6B2) (BD Biosciences 553087), FITC hamster anti-
mouse CD3e (145-2C11) (BD Biosciences 553061), PE annexin V (BD
Biosciences 556421), and Alexa Fluor 488 mouse anti-H2AX (pS139)
(N1-431) (BD Biosciences 560445).
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Isolation of G1- and S-phase cells from S0 and S1
erythroid subsets
E13.5 fetal livers were harvested fromwild-type BALB/cJ mice (Jackson
Laboratory stock no. 000651), mechanically dissociated, resuspended at
106 cells/ml, and maintained at 37°C for 15 min with Iscove’s modified
Dulbecco’smedium (IMDM) (L-glutamine, 25mMHepes) (Gibco), 20%
fetal calf serum (Gibco, HyClone), penicillin/streptomycin (100 U/ml;
Invitrogen), 10−4 M b-mercaptoethanol (Sigma), and Epo (2 U/ml).
Hoechst 33342 (5 mg/ml; Invitrogen H3570) was added for 40 min at
37°C. Cells were collected, washed, and labeled with antibodies to
CD71, Ter119, and lineage markers and with the cell viability dye
7AAD (BD Biosciences 559925). Cells were then sorted on a FACSAria
(BD Biosciences). G1- and S-phase cells in the S0 and S1 subsets were
gated on the basis ofDNAcontent, as reflected byHoechst fluorescence.
Cell cycle analysis
Pregnant female mice at midgestation were injected with BrdU
[200 ml of stock (10 mg/ml) in phosphate-buffered saline (PBS)] intra-
peritoneally. E13.5 embryos were harvested 30 min later. To determine
DNA replication rate in vitro, cells were pulsed at a final concentration
of 33 mM BrdU for 30 min. Cells were immediately labeled with the
LIVE/DEADKit (InvitrogenL23105), fixed, andpermeabilized. Erythroid
subsets were identified using anti-CD71 (BD Biosciences 113812) and
anti-Ter119 (BD Biosciences 553673). BrdU incorporation and DNA
content were detected by biotin-conjugated anti-BrdU (Abcam ab171059),
streptavidin-conjugated APC (Invitrogen S868), and 7AAD (BD Bio-
sciences 559925).
Measurement of S-phase duration
Pregnant female mice were intraperitoneally injected with 200 ml of
EdU (3.3mol/25 gmouse), followed either 1 or 2 hours later with BrdU
(3.3 mmol/25 g mouse), and sacrificed 20 min following the second
injection. Fetal livers were labeled with lineage markers Ter119 and
CD71, and S0 and S1 cells were sorted. Sorted subsets were then labeled
with the LIVE/DEAD Kit (Invitrogen L23105), fixed in 70% ethanol,
denatured in 4 M hydrochloric acid, and washed in phosphate/citric
buffer. EdU incorporation was detected using the Click-iT EdU Alexa
Fluor 488 Flow Cytometry Assay Kit (Invitrogen C10425), and BrdU
incorporation was detected using Alexa Fluor 647 mouse anti-BrdU
(Invitrogen B35133).
In vitro CFUe expansion cultures (51, 82)
To isolate Ter119-negative cells, fresh fetal liver cells were stained with
biotin-conjugated anti-Ter119 (BDBiosciences 553672) at a 1:100 ratio,
followed by EasySep magnetic separation (StemCell Technologies).
Cells were grown in StemPro-34 serum-free medium supplemented
with nutrient supplement (Invitrogen), 1 mM Dex (Sigma), stem cell
factor (SCF) (100 ng/ml; PeproTech), insulin-like growth factor
1 (40 ng/ml; PeproTech), Epo (2 U/ml), penicillin/streptomycin
(100 U/ml; Invitrogen), and 2mM L-glutamine (Invitrogen). Cells were
maintained at 2 × 106 cells/ml and supplemented daily with fresh me-
dium and growth factors. To test the effect of roscovitine on p57KIP2−/−
fetal liver cells in expansion culture, cells were grown andmaintained as
described above with the additional daily supplement of 0.5 mM ros-
covitine (EMDMillipore 557360). To switch to differentiationmedium,
after being maintained in expansion medium for 4 to 5 days, Ter119-
negative cells were isolated again using EasySep magnetic beads (Stem-
Cell Technologies). Cells were then transferred to IMDM (L-glutamine,
25mMHepes) (Gibco), 20% fetal calf serum (Gibco, HyClone), penicillin/
streptomycin (100U/ml; Invitrogen), 10−4M b-mercaptoethanol (Sigma),
and Epo (2 U/ml).
Retroviral transduction with p57 constructs
Retroviral constructs were generated in the MSCV-IRES-hCD4 vector
backbone, as described (23). p57 mutant (p57T329A) was previously
described (23). CDK-binding mutants defective of p57W50G and
p57F52A/F54A were generated using PCR with the following primers:
CCAGAACCGCGGGGACTTCAACTTCC and TCCTCGGCGT-
TCAGCTCG (for p57W50G) and CGCCCAGCAGGATGTGCCT-
CTTC and TTGGCGTCCCAGCGGTTCTGGTC (for p57F52A/
F54A). The entire open reading frame was sequenced to verify cor-
rect mutagenesis. Viral supernatants were prepared as described
(23). S0 cells were transduced by spin infection at 2000 rpm, 30°C
for 1 hour in fibronectin-coated dishes supplemented with polybrene
(4 mg/ml) (Sigma). Cells were incubated with SCF (100 ng/ml) and
interleukin-3 (IL-3) (10 ng/ml; PeproTech) overnight before cell
cycle analysis.
Knockdown experiments
shRNA targeting p57KIP2 (clone SM22685-D-5 V2MM_81921) was
subcloned into the LMP (MSCV/LTRmiR30-PIG) microRNA-adapted
retroviral vector containing an “IRES-GFP” reporter (OpenBiosystems).
Similarly, a nonsilencing negative control shRNA (RHS4971, Open Bio-
systems) that is processed by the endogenous RNA interference pathway
but will not target anymRNA sequence inmammals was subcloned into
LMP. Sorted S0 cells were transduced with retroviral vectors, expressing
shRNA for 16 hours in the presence of SCF and IL-3. Cells were then
cultured for Epo ± Dex for 20 to 72 hours before cell cycle analysis.
Quantitative RT-PCR
Total RNA was isolated from fetal liver cells using the AllPrep DNA/
RNAMicro Kit and the RNeasy Micro Kit (Qiagen) and quantified by
the Quant-iT RiboGreen RNA Reagent Kit (Thermo Scientific). The
SuperScript III first-strand synthesis system (Invitrogen) was used in
reverse transcription. qPCR was conducted in the ABI 7300 sequence
detection system with TaqMan reagents and TaqMan MGB probes
(Applied Biosystems).
TaqMan probes
The following TaqMan probes were used: b-actin (Mm02619580_g1),
b-globin (Mm01611268_g1), p21CIP1 (Mm00432448_m1), p27KIP1
(Mm00438168_m1), and p57KIP2 (Mm01272135_g1).
Western blot analysis
Sorted fetal liver cells or fetal liver cells from expansion and differenti-
ation cultures were incubated in lysis buffer [1%NP-40, 50mM tris (pH
7.4), 150 mM NaCl, 1 mM EDTA, 10% glycerol supplemented with
protease inhibitors] and rotated at 4°C for 30 min. Supernatants were
prepared by centrifugation at 4°C for 15min and quantified by the BCA
ProteinAssayKit (Pierce). Protein electrophoresis was carried out using
the NuPAGENovex Bis-Tris Gel System and the Bolt Bis-Tris Plus Gel
System (Invitrogen). Polyvinylidene difluoridemembraneswere probed
with antibodies against p57KIP2 (Abcam ab75974), b-actin (Abcam
ab8227), p21CIP1 (Abcam ab109199), p27KIP1 (Cell Signaling Technol-
ogy 3698), and a-globin (Abcam ab92492). Target protein bands were
detected by ChemiDoc XRS+ system (Bio-Rad) and quantified using
Image Lab software (Bio-Rad).Negative and positive controls were used
in all Western blots, consisting of lysates of either 3T3 or 293T cells,
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transduced with either “empty vector” or retroviral vector expressing
the relevant test protein.
DNA combing
Freshly harvested fetal liver cells were allowed to recover in Epo-
containing medium at 37°C for 4 hours. They were then pulsed with
IdU (25 mM) for 10 min, followed immediately, without intervening
washes, by a CldU pulse (200 mM) for 20 min. Cells were labeled with
CD71 and Ter119 antibodies as described above, and subsets S0 and S1
were sorted by flow cytometry. The sorted cells were washed in PBS and
embedded in agarose plugs (0.75% low-melt agarose; Bio-Rad). Plugs
were incubated in proteinase K (0.2 mg/ml; Roche) solution at 37°C
for 48 hours. After extensive washing, agarose plugs were melted and
digested with b-agarase. Genomic DNA was gently resuspended in
0.2 M MES buffer (pH 5.4) and combed on silanized coverslips using
the Molecular Combing System (Genomic Vision). Combed DNA was
denatured in 2 M hydrochloric acid and labeled with rat anti-BrdU
(Abcam ab6326) and Alexa Fluor 594 goat anti-rat immunoglobulin
G (IgG; Life Technologies A11007) to identify IdU tracks, with mouse
anti-BrdU (BD Biosciences 347580) and Alexa Fluor 488 goat anti-
mouse IgG (Invitrogen A11029) to identify CldU tracks, and with anti–
single-stranded DNA rabbit IgG (Immuno-Biological Laboratories Co.
Ltd. 18731), biotin-conjugated goat anti-rabbit IgG (BD Biosciences
550338), BV421 streptavidin (BioLegend 405226), and BV421 anti-
human IgG (BioLegend 409317) to identify single-strandedDNA fibers.
Fluorescence microscopy was carried out on a Zeiss Axioskop 40
fluorescence microscope. Separate exposures were taken for red, blue,
and green fluorescence for each field andmerged using the GNU Image
Manipulation Program (GIMP). Up to 40 consecutive fields were
photographed and merged digitally for each of the final image files that
were then analyzed by a scientist that was blinded to sample identity.
DNA track lengths weremeasured using GIMP. IdU track lengths were
tracks that were labeled only with green fluorescence. Examples of orig-
inal fluorescence images are shown in fig. S9 and in the Supplementary
Image files. The spreadsheet data set for the DNA combing experiment
in Fig. 6 and fig. S7 is in data file S1.
Cell cycle and gH2AX analysis in vivo
Pregnant female mice were intraperitoneally injected with 200 ml of
BrdU (10 mg/ml). Mice were sacrificed at 30 min after injection. Fetal
livers were fixed and permeabilized; digested with deoxyribonuclease
(DNase) I; labeled for BrdU incorporation, non-erythroid lineage
markers, and cell surface markers CD71 and Ter119; and analyzed
by flow cytometry. Where indicated, cells were labeled with antibodies
against gH2AX before the DNase I digestion.
Statistical analysis
One-way analysis of variance (ANOVA) was used to compare mea-
sured parameters from the three different genotypes (wild-type,
p57KIP2+/−m, and p57KIP2−/−) with the GraphPad Prism 7.0 software.
Statistical significance of the DNA combing data was assessed using
Student’s t test. Mann-Whitney test was used for non-normally distrib-
uted data sets.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/5/e1700298/DC1
fig. S1. The transition from self-renewal to differentiation at S0/S1 is associated with a transient
increase in intra–S-phase DNA synthesis rate.
fig. S2. p57KIP2 exerts dose-dependent inhibition of DNA synthesis within S-phase cells.
fig. S3. Increased gH2AX in p57KIP2-deficient fetal liver.
fig. S4. Analysis of p57KIP2-deficient CFUe undergoing self-renewal in vitro.
fig. S5. Increased cell death in p57KIP2−/− S0 CFUe during self-renewal in vitro.
fig. S6. CFUe self-renewal requires the CDK-binding and inhibition functions of p57KIP2.
fig. S7. DNA combing analysis of freshly explanted fetal livers from wild-type and p57KIP2+/−m
embryos associated with the experiment in Fig. 6.
fig. S8. DNA combing experiments.
fig. S9. DNA combing: Example of fluorescence image file used for scoring data.
data file S1. Spreadsheet containing the data set for the DNA combing experiment in Fig. 6.
Image files
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